Stock listing
ERV2 Stock Price, News, Filings & Events — Molecule Holdings Inc.
Selected listing: ERV2 · MUN · EUR · DE
This page tracks Molecule Holdings Inc.'s ERV2:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ERV2:MUN. ERV2:MUN is the stock-level entry point for investors researching Molecule Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Molecule Holdings Inc. (MLCL) is a public company based in Canada with a market capitalization of approximately $347,126.1. The company operates in the cannabis sector, focusing on innovative solutions and products. Molecule Holdings aims to leverage its expertise to capture opportunities in the evolving market landscape.
- Ticker
- ERV2:MUN
- Asset type
- Stock
- Market cap
- $353,335
- Sector
- Consumer Non-Durables
- Industry
- Beverages: Non-Alcoholic
- Exchange
- MUN
- Currency
- EUR
Molecule Holdings Inc. ERV2:MUN stock context
This page tracks Molecule Holdings Inc.'s ERV2:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ERV2:MUN. ERV2:MUN is the stock-level entry point for investors researching Molecule Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Molecule Holdings Inc. (MLCL) is a public company based in Canada with a market capitalization of approximately $347,126.1. The company operates in the cannabis sector, focusing on innovative solutions and products. Molecule Holdings aims to leverage its expertise to capture opportunities in the evolving market landscape.
Latest news from Molecule Holdings Inc.
Molecule Holdings Inc. Announces Issuance of Partial Revocation Order to Complete Secured Debenture Restructuring and Private Placement
August 31, 2026
Molecule Holdings Inc. Provides Corporate Update
October 27, 2025
Molecule Holdings Inc. Announces Additional Amendment and Conversion Transaction of Unsecured Debentures
June 2, 2025
Molecule Holdings Inc. Announces Issuance of Third Partial Revocation Order
March 4, 2025
Molecule Holdings Inc. Announces Amendment and Conversion of Unsecured Debentures
November 28, 2024
Research Molecule Holdings Inc.
Molecule Holdings Inc. investor report
Review AI stock analysis and investor report context for ERV2:MUN.
Molecule Holdings Inc. company profile
View the public company page for Molecule Holdings Inc. on 6ix.
Molecule Holdings Inc. news
Read company news and market updates connected to Molecule Holdings Inc..
Molecule Holdings Inc. investor events
Find investor webinars, events, and replay context for Molecule Holdings Inc..
Alternate listings
MLCL:CSE
CA · CAD
Alternate listing for Molecule Holdings Inc.; the primary context on this page is ERV2:MUN.
EVRRF:OTC
US · USD
Alternate listing for Molecule Holdings Inc.; the primary context on this page is ERV2:MUN.
ERV2:FWB
DE · EUR
Alternate listing for Molecule Holdings Inc.; the primary context on this page is ERV2:MUN.
MLCL:NEO
CA · CAD
Alternate listing for Molecule Holdings Inc.; the primary context on this page is ERV2:MUN.
A2QES2:LS
DE · EUR
Alternate listing for Molecule Holdings Inc.; the primary context on this page is ERV2:MUN.
A2QES2:LSX
DE · EUR
Alternate listing for Molecule Holdings Inc.; the primary context on this page is ERV2:MUN.
ERV2:SWB
DE · EUR
Alternate listing for Molecule Holdings Inc.; the primary context on this page is ERV2:MUN.